Am Heart J

1. GIROLAMO O, Ismail MD, Tavella R, Ooi EL, et al
   Functional coronary angiogram findings in angina with non-obstructive coronary arteries patients with coronary slow flow.
   Am Heart J. 2026;292:107287.
   

   >> Share

   
   
2. YOSHIDA Y, Zu Y, Aguilar D, Ferdinand KC, et al
   Cumulative effect of hyperglycemia and insulin resistance on cardiac dysfunction: The coronary artery risk development in young adults (CARDIA) study.
   Am Heart J. 2026;292:107276.
   

   >> Share

   
   
3. FUR CB, Olsen NT, Lassen JF, Eftekhari A, et al
   Design and rationale of aspirin versus aspirin and fondaparinux prior to early invasive strategy in patients with NSTEMI: The FOXY trial.
   Am Heart J. 2026;292:107274.
   

   >> Share

   
   
4. SORGAARD MH, Kristensen AT, Eskesen K, Kofoed KF, et al
   Coronary Computed Tomography Angiography Versus Invasive Coronary Angiography for Interventional Triage in Acute Coronary Syndrome - Design of the Randomized TRACTION Trial.
   Am Heart J. 2025 Dec 6:107325. doi: 10.1016/j.ahj.2025.107325.
   

   >> Share

   
   

   
   Am J Cardiol

5. KOVACIC M, Leibundgut G, Cocoi M, Bozinovic N, et al
   Deep Dive Rendezvous as a Novel Alternative Technique for Conventional Externalization in Retrograde Chronic Total Occlusion Interventions.
   Am J Cardiol. 2025;257:275-282.
   

   >> Share

   
   
6. ALANEZI M, Barichello S, Nouraei H, Singh SM, et al
   Relationship Between QRS Fragmentation on Electrocardiogram and Myocardial Scar Characterization on Cardiac Magnetic Resonance Imaging in Patients With Ischemic and Nonischemic Cardiomyopathy.
   Am J Cardiol. 2025;257:147-152.
   

   >> Share

   
   
7. DI PIETRO G, Improta R, De Filippo O, Bruno F, et al
   Systematic Review and Meta-analysis of Short-Term Outcomes in Patients Following Protected High-Risk PCI.
   Am J Cardiol. 2025 Oct 3:S0002-9149(25)00556.
   

   >> Share

   
   
8. HANSEN KN, Christiansen EH, Ellert-Gregersen J, Eftekhari A, et al
   Impact of Diabetes Mellitus on 5-year Outcomes after PCI with a Polymer-Free Drug-Coated Stent or a Biodegradable Polymer Ultra-thin Strut Stent.
   Am J Cardiol. 2025 Oct 2:S0002-9149(25)00601.
   

   >> Share

   
   
9. CARDAIOLI F, Sciarretta T, Arturi F, Fabris T, et al
   Unmasking Myocardial Bridge-Related Ischemia by Quantitative Flow Ratio Functional Evaluation.
   Am J Cardiol. 2026;258:112-118.
   

   >> Share

   
   
10. YOUSAFZAI O, Kanwal K, Annie F, Rinehart S, et al
    One-Year Outcomes in PAD Patients with Elevated Lipoprotein(a): A Propensity-Matched Analysis.
    Am J Cardiol. 2025 Sep 1:S0002-9149(25)00506.
    

    >> Share

    
    
11. ANASTASOPOULOU M, Karanasos A, Grafanaki K, Almpanis G, et al
    Incidence of Elevated Cardiac Biomarkers in Patients Presenting to the Emergency Department With Allergic Symptoms: Implications for the Diagnosis of Kounis Syndrome.
    Am J Cardiol. 2026;258:1-8.
    

    >> Share

    
    
12. TANIK VO, Guner A, Serin E, Calik AN, et al
    Ostial Stent Implantation or Crossover Stenting for Ostial LAD Lesions: The Multicenter CROSS-ANATOLIA Registry.
    Am J Cardiol. 2025;257:131-140.
    

    >> Share

    
    
13. STREPKOS D, Alexandrou M, Mutlu D, Carvalho PEP, et al
    Multiple Versus Single Vessel CTO PCI in the Same Hospitalization: Data From the PROGRESS-CTO Registry.
    Am J Cardiol. 2025;257:77-83.
    

    >> Share

    
    

    
    Am J Emerg Med

14. LAUGHTER C, Alsayyed A, Shubair M, Johnson A, et al
    Comparing physician and advanced care provider use of opioids for treatment of acute chest pain in the emergency department.
    Am J Emerg Med. 2025;99:110-113.
    

    >> Share

    
    

    
    Angiology

15. DU Y, Deng X, Song Y, Yan J, et al
    Prognostic Value of the Systemic Immune-Inflammation Index in Patients With Acute Myocardial Infarction: A Systematic Review and Meta-Analysis.
    Angiology. 2025 Dec 12:33197251392661. doi: 10.1177/00033197251392661.
    

    >> Share

    
    
16. YANG H, Xiong P, Song H, Deng Y, et al
    NLRC5 and NF-kappaB Signaling: Implications for Atherosclerotic Plaque Formation in Acute Coronary Syndromes.
    Angiology. 2025 Dec 4:33197251392646. doi: 10.1177/00033197251392646.
    

    >> Share

    
    

    
    Ann Intern Med

17. 
    Correction: Chronic Coronary Artery Disease.
    Ann Intern Med. 2025 Dec 9. doi: 10.7326/ANNALS-25-05126.
    

    >> Share

    
    

    
    BMJ

18. 
    Correction: Ionising radiation and cardiovascular disease: systematic review and meta-analysis.
    BMJ. 2025;391:r2557.
    

    >> Share

    
    
19. 
    Redressing inequities in women's cardiovascular health.
    BMJ. 2025;391:r2617.
    

    >> Share

    
    

    
    Catheter Cardiovasc Interv

20. ULACIA FLORES P, Cieza T, Ouarrak S, Ruhl A, et al
    Clinical Impact of Concordant and Discordant Physiology Parameters Post-Percutaneous Coronary Intervention in the EASY-PREDICT Study.
    Catheter Cardiovasc Interv. 2025 Oct 17. doi: 10.1002/ccd.70266.
    

    >> Share

    
    
21. SAAD M, Elhakim A, Lutter G, Elsoudi M, et al
    Expect the Unexpected, Acute Left Main Coronary Artery Occlusion During TAVI: A Case Series.
    Catheter Cardiovasc Interv. 2025;106:3837-3845.
    

    >> Share

    
    
22. CENNI N, Ballo P, Chechi T, Rosso G, et al
    Spontaneous Coronary Artery Dissection: Cardiovascular Events Incidence and Quality of Life Evaluation in a Single-Center 10 Years' Experience.
    Catheter Cardiovasc Interv. 2025;106:3819-3836.
    

    >> Share

    
    
23. AKRAWI D, Kadappu K, Xu J, Badie TYN, et al
    VERMONT: Vessel Fractional Flow Reserve (vFFR) Assessment of Stenosis Severity: A Prospective Study.
    Catheter Cardiovasc Interv. 2025;106:3757-3765.
    

    >> Share

    
    
24. SHIBATA N, Morishima I, Tanaka A, Yoshioka N, et al
    Post-Discharge Major Adverse Events in Patients Surviving Acute Unprotected Left Main Coronary Artery Occlusion.
    Catheter Cardiovasc Interv. 2025;106:3774-3782.
    

    >> Share

    
    
25. ZHOU J, Gao W, Wang W, Zhang F, et al
    Prognostic Value of Functional Incomplete Revascularization for Intermediate Coronary Stenosis in Patients With Valvular Surgery.
    Catheter Cardiovasc Interv. 2025;106:3766-3773.
    

    >> Share

    
    
26. MUTLU D, Rempakos A, Strepkos D, Carvalho PEP, et al
    Drug-Coated Balloons in Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the PROGRESS-CTO Registry.
    Catheter Cardiovasc Interv. 2025 Oct 13. doi: 10.1002/ccd.70240.
    

    >> Share

    
    
27. SEDRAKYAN S, Laband W, Khan MF
    Sex Differences in the Prescription of P2Y12 Inhibitor Agents Following Percutaneous Coronary Intervention.
    Catheter Cardiovasc Interv. 2025 Oct 13. doi: 10.1002/ccd.70269.
    

    >> Share

    
    
28. SIIG JJ, Sondergaard MM, Rasmussen LD, Christiansen EH, et al
    Prognosis of Calcified Lesions Treated With PCI in Patients With Chronic Coronary Artery Disease.
    Catheter Cardiovasc Interv. 2025;106:3653-3664.
    

    >> Share

    
    
29. COHEN RM, Di Muro FM, Sartori S, Vogel B, et al
    Predictive Value of the Academic Research Consortium High Bleeding Risk Criteria in Self-Identified Black Individuals Undergoing Percutaneous Coronary Intervention.
    Catheter Cardiovasc Interv. 2025 Oct 12. doi: 10.1002/ccd.70203.
    

    >> Share

    
    
30. PLANKA RM, Herold L, Glantschnig T, Sommer G, et al
    Applying DanGer Shock Eligibility Criteria to a Real-World Cohort of Cardiogenic Shock Patients.
    Catheter Cardiovasc Interv. 2025;106:3617-3627.
    

    >> Share

    
    
31. CHEN A, Pan K
    The Thigh Saphenous Vein Versus the Calf Saphenous Vein: Searching for the Optimal Conduit for Coronary Artery Bypass Grafting.
    Catheter Cardiovasc Interv. 2025 Oct 12. doi: 10.1002/ccd.70270.
    

    >> Share

    
    
32. AHMED M, Fahim MAA, Humayun M, Sajid B, et al
    Efficacy and Safety of Colchicine for Secondary Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis.
    Catheter Cardiovasc Interv. 2025;106:3675-3689.
    

    >> Share

    
    
33. WANG W, Huang B
    Recurrent Chest Pain Due to Spontaneous Coronary Artery Dissection Diagnosed by Optical Coherence Tomography.
    Catheter Cardiovasc Interv. 2025;106:3585-3587.
    

    >> Share

    
    
34. CHEN T, Zhao J, He Y, Fang C, et al
    Safety and Efficacy of Intravascular Lithotripsy System: A Prospective, Multicenter Clinical Trial (The VIGOUR Study).
    Catheter Cardiovasc Interv. 2025;106:3599-3608.
    

    >> Share

    
    
35. KLADOU E, Strepkos D, Alexandrou M, Mutlu D, et al
    Modification Procedures for Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the PROGRESS-CTO Registry.
    Catheter Cardiovasc Interv. 2025 Oct 12. doi: 10.1002/ccd.70228.
    

    >> Share

    
    
36. NAKATA M, Abe M, Chinen T, Nakamura K, et al
    Comparative Analysis of Intravascular Lithotripsy With and Without Atherectomy in Severely Calcified Coronary Lesions Using OCT and OFDI.
    Catheter Cardiovasc Interv. 2025;106:3541-3550.
    

    >> Share

    
    
37. ARIYANTI D, Hibatulloh MF, Pramusinta CK, Tohari AI, et al
    The Role of CHA(2)DS(2)-VASc Score in Predicting Clinical Complications Following Primary Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
    Catheter Cardiovasc Interv. 2025 Oct 5. doi: 10.1002/ccd.70165.
    

    >> Share

    
    
38. HASSAN A, Mansour A, Elkasaby MH, Ramadan S, et al
    Drug-Coated Balloon Versus Drug-Eluting Stent for De Novo Lesions of Large Coronary Arteries: A Systematic Review and Meta-Analysis of Angiographic and Clinical Outcomes.
    Catheter Cardiovasc Interv. 2025 Oct 1. doi: 10.1002/ccd.70223.
    

    >> Share

    
    
39. CALAQUIAN LL, Dean JL, Howes SA, Ramirez AY, et al
    Dual Antiplatelet Therapy in NSTEMI: Successfully Navigating the DAPT Dilemma.
    Catheter Cardiovasc Interv. 2025;106:3512-3516.
    

    >> Share

    
    
40. SHABEER H, Sattar S, Arti FNU, Kumar H, et al
    Comparative Outcomes of Drug-Eluting Balloons Versus Drug-Eluting Stents in Patients With Diabetes Undergoing PPCI.
    Catheter Cardiovasc Interv. 2025;106:3506-3511.
    

    >> Share

    
    
41. KLEIN B, Mandava S, Shatanof R, Sendil S, et al
    Real-World Outcome of Coronary Orbital Atherectomy in Diabetic Versus Non-Diabetic Patients: A Single-Center Experience.
    Catheter Cardiovasc Interv. 2025;106:3481-3488.
    

    >> Share

    
    
42. KUMAR S, Kearney KE, Chung CJ, Elison D, et al
    Frailty and Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention.
    Catheter Cardiovasc Interv. 2025 Sep 23. doi: 10.1002/ccd.70219.
    

    >> Share

    
    
43. MA Y, Song X, Tang L, Kong L, et al
    A Novel Approach to Treat Coronary Chronic Total Occlusion: Balloon-Assisted Revascularization-A Retrospective Study.
    Catheter Cardiovasc Interv. 2025;106:3397-3402.
    

    >> Share

    
    
44. TAKAMURA TA, Nakagawa C, Masaki M, Akita S, et al
    Three-Year Outcome of Drug Coated Balloon Angioplasty Following Atherectomy for Severely Calcified Coronary Lesions.
    Catheter Cardiovasc Interv. 2025;106:3465-3472.
    

    >> Share

    
    
45. MARRONE A, Erriquez A, Verardi FM, Colaiori I, et al
    Additional Value of Optical Coherence Tomography-Derived Virtual Flow Reserve for Percutaneous Coronary Intervention Guidance.
    Catheter Cardiovasc Interv. 2025 Sep 23. doi: 10.1002/ccd.70207.
    

    >> Share

    
    
46. HAOKAO G, Genrui C, Huan W, Chengxiang L, et al
    Coronary Artery Fistulous Perforation Effectively Managed During Chronic Total Occlusion Recanalization: A Case Report.
    Catheter Cardiovasc Interv. 2025;106:3403-3408.
    

    >> Share

    
    
47. CHENG J, Song C, Wang HY, Lin Z, et al
    pREdicting Long-Term Major advErse carDiac and Cerebrovascular Events After Percutaneous coronarY Intervention: The REMEDY Score.
    Catheter Cardiovasc Interv. 2025 Oct 17. doi: 10.1002/ccd.70244.
    

    >> Share

    
    
48. CERRATO E, Piedimonte G, Franzino M, Marengo G, et al
    Contemporary Use of Coils During Percutaneous Coronary Intervention: Insights From the Multicenter COILSEAL Registry.
    Catheter Cardiovasc Interv. 2025 Oct 21. doi: 10.1002/ccd.70233.
    

    >> Share

    
    
49. KALHOR P, Nowrouzi P, Ghahari P, Mehrani M, et al
    Can Eptifibatide Rewrite the NSTEMI Story? (Eptifibatide vs. Standard Care for NSTEMI: A 5-Year Analysis of Major Adverse Cardiovascular Events).
    Catheter Cardiovasc Interv. 2025;106:3928-3938.
    

    >> Share

    
    
50. HILL AP, Wallace RL, Chaturvedi A, Frisancho FT, et al
    Comparative Visual Analysis of Coronary Slow Flow and Myocardial Blush Grade in Relation to Invasive Testing for Coronary Microvascular Dysfunction.
    Catheter Cardiovasc Interv. 2025;106:3953-3958.
    

    >> Share

    
    
51. KARAKURT ST, Karakurt H
    The C-Reactive Protein to Albumin Ratio Is a Novel Marker for Predicting Functionally Significant Coronary Artery Stenosis in Chronic Coronary Syndrome Patients.
    Catheter Cardiovasc Interv. 2025;106:3963-3968.
    

    >> Share

    
    
52. GEBREMEDHIN ML, Sigdel M, Ruixue Z, Du B, et al
    Efficacy of the EBU Guide Catheter as a Bailout and Selective Strategy in Challenging Right Coronary Artery Interventions.
    Catheter Cardiovasc Interv. 2025;106:3982-3991.
    

    >> Share

    
    
53. ZHANG L, Zhang Z, Yu Y, Han X, et al
    Rhabdomyolysis Complicated by Acute Myocardial Infarction: A Case Report.
    Catheter Cardiovasc Interv. 2025 Dec 10. doi: 10.1002/ccd.70430.
    

    >> Share

    
    

    
    Chest

54. WANG J, Wang G
    Could Single-Inhaler Triple Therapy Be At Increased Risk of Major Adverse Cardiovascular Events in COPD?
    Chest. 2025;168:e198-e199.
    

    >> Share

    
    
55. CIURZYNSKI M, Pruszczyk P
    Exercise Doppler Echocardiography of the Right Heart and Pulmonary Circulation in Patients With Cardiovascular Risk Factors: Chance or Unnecessary Exam?
    Chest. 2025;168:1288-1290.
    

    >> Share

    
    

    
    Circulation

56. XU L, Hrybouski S, Liao TE, Dong JN, et al
    Geometric Features of Ventricular Tachycardia Corridors in Patients With Ischemic Cardiomyopathy.
    Circulation. 2025;152:1608-1620.
    

    >> Share

    
    
57. SHARIF A
    Why We Must Rethink Kidney Transplantation as a Cardiovascular Risk-Reducing Intervention in Kidney Failure.
    Circulation. 2025;152:1591-1593.
    

    >> Share

    
    

    
    Clin Cardiol

58. ZHANG Y, Yu G, Wang C, Song J, et al
    Association of Ticagrelor Metabolic SNPs With Adverse Drug Reactions in Patients With Acute Coronary Syndrome.
    Clin Cardiol. 2025;48:e70232.
    

    >> Share

    
    
59. MOCHA MR, Hueb W, Rezende PC, de Oliveira Laterza Ribeiro M, et al
    Underestimation of Stent Efficacy: Untreated Artery Events Distort Coronary Intervention Outcomes.
    Clin Cardiol. 2025;48:e70229.
    

    >> Share

    
    
60. WEI T, Shen S, Shan T, Wan T, et al
    Exploring the Link: Marijuana Use Patterns and Their Impact on Coronary Heart Disease Risk.
    Clin Cardiol. 2025;48:e70223.
    

    >> Share

    
    
61. TIBILLI H, Markirt S
    Concerns and Considerations Regarding the Study on Epicardial Fat Thickness as a Marker for Coronary Artery Disease in Diabetic Patients.
    Clin Cardiol. 2025;48:e70205.
    

    >> Share

    
    

    
    Crit Care Med

62. WINISZEWSKI H, Puyraveau M, Kimmoun A, Piton G, et al
    Impact of Conservative Vs. Liberal Extracorporeal Oxygen Target During Venoarterial Extracorporeal Membrane Oxygenation Support for Cardiogenic Shock: A Pilot Randomized Control Trial.
    Crit Care Med. 2025;53:e2552-e2561.
    

    >> Share

    
    

    
    Eur Heart J

63. ANDERSEN MH, Jensen JM, Kanstrup H, Sand NPR, et al
    Low-density lipoprotein cholesterol and cardiovascular risk in the absence of calcifications on computed tomography: the Western Denmark Heart Registry.
    Eur Heart J. 2025;46:5062-5072.
    

    >> Share

    
    
64. VOLLEBERG RHJA, Luttikholt TJ, van der Waerden RGA, Cancian P, et al
    Artificial intelligence-based identification of thin-cap fibroatheromas and clinical outcomes: the PECTUS-AI study.
    Eur Heart J. 2025;46:5032-5041.
    

    >> Share

    
    
65. BERRY C, Stanley B, Duklas P, Layland J, et al
    Fractional flow reserve vs angiography in non-ST- elevation myocardial infarction: long-term results of the FAMOUS-NSTEMI trial.
    Eur Heart J. 2025 Dec 8:ehaf925. doi: 10.1093.
    

    >> Share

    
    

    
    Heart

66. BALMFORTH C, McDermott M, Khaing P, Dweck MR, et al
    Identification and management of non-obstructive high-risk coronary artery plaque.
    Heart. 2025;112:13-20.
    

    >> Share

    
    

    
    Hypertension

67. SRIDHAR VS, Kugathasan L, Lytvyn Y, Deng Y, et al
    Cardiovascular-Kidney Effects of Dapagliflozin in Patients at Cardiovascular Risk With or Without Type 2 Diabetes: Results of a Randomized, Double-Blind, Placebo-Controlled Trial.
    Hypertension. 2025 Dec 5. doi: 10.1161/HYPERTENSIONAHA.125.25955.
    

    >> Share

    
    
68. DARLING AM, Dominguez CM, Mogle J, Fadel PJ, et al
    Affective Responsivity and Cardiovascular Stress Reactivity in Depression.
    Hypertension. 2025 Dec 11. doi: 10.1161/HYPERTENSIONAHA.125.25452.
    

    >> Share

    
    

    
    J Am Coll Cardiol

69. GANATRA S, Barac A, Armenian S, Cambareri C, et al
    Diagnosis and Management of Cardiovascular Adverse Effects of Targeted Oncology Therapies: Bruton's Tyrosine Kinase, Immune Checkpoint, and Vascular Endothelial Growth Factor Inhibitors: 2025 ACC Concise Clinical Guidance: A Report of the American Col
    J Am Coll Cardiol. 2025 Dec 10:S0735-1097(25)09916.
    

    >> Share

    
    
70. WILLIAMS KA SR, Aggarwal M, Agustina R, Dastmalchi LN, et al
    Nutrition and Front-of-Package Food Labeling as a Catalyst for Cardiovascular Health: 2025 ACC Concise Clinical Guidance: A Report of the American College of Cardiology Solution Set Oversight Committee.
    J Am Coll Cardiol. 2025 Dec 5:S0735-1097(25)10156.
    

    >> Share

    
    
71. OSTROMINSKI JW, Neuen BL, Claggett BL, Filippatos G, et al
    Timing of Cardiovascular and Kidney Benefits With Finerenone in Heart Failure and Chronic Kidney Disease With Type 2 Diabetes.
    J Am Coll Cardiol. 2025 Nov 18:S0735-1097(25)10071.
    

    >> Share

    
    
72. KANG YM, Giugliano RP, Keech AC, Lopez JAG, et al
    Obesity-Associated Cardiovascular Risk and Benefit From PCSK9 Inhibition: A Prespecified Analysis From FOURIER.
    J Am Coll Cardiol. 2025 Dec 10:S0735-1097(25)10005.
    

    >> Share

    
    

    
    J Electrocardiol

73. TOMCSANYI J, Tomcsanyi K
    Normokalemic Littmann sign due to STEMI.
    J Electrocardiol. 2025;93:154122.
    

    >> Share

    
    
74. POSELYANINOV AS, Tsvetkova AS, Khomenko PV, Grubbe ME, et al
    Duration of electrocardiographic T(PEAK)-T(END) interval in ischemia: Dispersion of repolarization vs. myocardium area at risk.
    J Electrocardiol. 2025;93:154129.
    

    >> Share

    
    
75. KIVIMAKI K, Pohjantahti H, Hernesniemi J, Lyytikainen LP, et al
    The association between ST-segment depressions and sudden cardiac deaths and arrests after acute coronary syndrome.
    J Electrocardiol. 2025;93:154145.
    

    >> Share

    
    
76. DIGIROLAMO GJ, Kakouros N, Sorcini F, Sorcini SP, et al
    Non-conscious detection of ST-segment elevation during physician ECG interpretation.
    J Electrocardiol. 2025;93:154148.
    

    >> Share

    
    
77. STACEY RB, Prineas RJ, Zhang ZM, Psaty BM, et al
    Electrocardiographic criteria for silent myocardial infarction: Impact of different definitions on detection rates and prognostic significance in the atherosclerosis risk in communities (ARIC) study: A comparison with evolving bundle branch blocks.
    J Electrocardiol. 2025;94:154174.
    

    >> Share

    
    

    
    J Thorac Cardiovasc Surg

78. BAKAEEN FG
    NOBLEty and FAME to percutaneous coronary intervention not coronary artery bypass grafting: Not based on scientific credentials.
    J Thorac Cardiovasc Surg. 2025 Nov 22:S0022-5223(25)00984.
    

    >> Share

    
    

    
    Lancet

79. TAVILDARI A, Dallenbach L, Sierro C, Jovic D, et al
    45-year follow-up after Gruntzig's coronary angioplasty.
    Lancet. 2025;406:2750.
    

    >> Share

    
    

    
    Mayo Clin Proc

80. ZALAQUETT Z, Shukla N, Hajj J, El Helou MC, et al
    Cardiovascular Toxicity of Fluoropyrimidines: What We Know.
    Mayo Clin Proc. 2025 Dec 4:S0025-6196(25)00476.
    

    >> Share

    
    

    
    PLoS One

81. RINK L, Heisig J, Fink CE, Gonschorek C, et al
    "If it's necessary, it has to be done. And that's for the physician to decide, not me." Imaging techniques in monitoring routines in coronary heart disease and post-stroke patients: A qualitative interview study from the patients' perspective.
    PLoS One. 2025;20:e0338431.
    

    >> Share

    
    
82. WANG J, Chang T, Wang Y, Zhang J, et al
    Association between Anti-Helicobacter pylori IgG seropositivity on coronary heart disease and potential pathogenesis: a Mendelian randomization study.
    PLoS One. 2025;20:e0329137.
    

    >> Share

    
    
83. AMIDI B, Naderi N, Yoosefi Lebni J, Amin A, et al
    Multilevel obstacles to heart-healthy living in the context of Ischemic heart disease: A qualitative study.
    PLoS One. 2025;20:e0338298.
    

    >> Share

    
    
84. DAI Z, He C, Zeng H, Chen Y, et al
    The impact of hyperglycemia on prognosis in chronic obstructive pulmonary disease patients with coronary heart disease: A five-year prospective study.
    PLoS One. 2025;20:e0335935.
    

    >> Share

    
    

    
    Prog Cardiovasc Dis

85. KNOTT JD, Kronzer E, Anavekar N, Chareonthaitawee P, et al
    Radionuclide imaging techniques for assessing myocardial viability: Clinical applications, evidence, and future directions.
    Prog Cardiovasc Dis. 2025;93:51-59.
    

    >> Share

    
    
86. ALWAN M, El Ghazawi A, El Yaman A, Al Rifai M, et al
    SPECT Myocardial Perfusion Imaging in the Era of PET and Multimodality Imaging: Challenges and Opportunities.
    Prog Cardiovasc Dis. 2025;93:3-9.
    

    >> Share

    
    
87. VOHRA S, Sakul S, Agarwal V, Patel KK, et al
    Quantification of myocardial blood flow using PET: Current status, clinical applications, and future directions.
    Prog Cardiovasc Dis. 2025;93:10-20.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share